CONTRIBUTION and loan AGREEMENTContribution and Loan Agreement • July 21st, 2022 • Vickers Vantage Corp. I • Biological products, (no disgnostic substances)
THIS CONTRIBUTION AND LOAN AGREEMENT (this “Agreement”) is made and entered into as of March 18, 2019, by and between Scilex Holding Company, a Delaware corporation (the “Company”), Sorrento Therapeutics, Inc., a Delaware corporation (“Sorrento”), the stockholders of Scilex set forth on the signature pages hereto (each, a “Contributor” and, collectively, the “Contributors”), and Scilex Pharmaceuticals Inc., a Delaware corporation (“Scilex”). Certain capitalized terms used but not defined herein have the meanings ascribed thereto in that certain Agreement and Plan of Merger, dated as of March 18, 2019 (as may be amended, modified or supplemented from time to time, the “Merger Agreement”), by and among the Company, Sigma Merger Sub, Inc., a Delaware corporation (“Merger Sub”), Semnur Pharmaceuticals, Inc., a Delaware corporation (“Semnur”), and Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the Equityholders (the “Equityholders’ Rep
EXHIBIT 10.2 to S-11 CONTRIBUTION AND LOAN AGREEMENT dated as of ___________, 2003 by and between DELPHI CORPORATIONContribution and Loan Agreement • March 28th, 2003 • Delphi Properties Inc • Motor vehicle parts & accessories • New York
